After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk of death from any cause compared to those who took the other type of ...

Medtronic (NYSE: MDT) announced some personnel moves, including the departure of a longtime leader across multiple business ...

Medtronic, a healthcare technology company based in Ireland, plans to separate its diabetes business into a standalone, publicly traded company by the end of 2026.  The company announced the move May ...

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech ...

Philippine officials on Thursday condemned the Chinese coast guard, which it said used a powerful water cannon to target one of two Philippine fishing boats conducting marine research in the disputed ...

Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes ...

Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott ...

Q4 2025 Earnings Call Transcript May 21, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.62, expectations ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Medtronic (NYSE:MDT) reported better-than-expected fiscal Q4 earnings and revenue, while unveiling plans to spin off its ...